Haleos Labs Limited (NSE:HALEOSLABS)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Manufacturing of Active Pharmaceutical Ingredients and Their Intermediates	3.34B	3.45B	3.06B	3.16B	3.50B
Total	3.34B	3.45B	3.06B	3.16B	3.50B

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Exports	1.25B	1.38B	1.30B	1.04B	1.32B
Deemed Exports	16.22M	66.41M	53.10M	234.94M	310.45M
India	2.06B	2.00B	1.70B	1.87B	1.85B
Unallocated	9.15M	6.15M	7.97M	9.49M	24.43M
Total	3.34B	3.45B	3.06B	3.16B	3.50B

Data Source: S&P Global Market Intelligence Last updated: Nov 11, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 12, 2026

Data Sources Report a data error